This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Financial Assistance Now Available For People With Acute Lymphoblastic Leukemia

-- Sigma-Tau Pharmaceuticals, Inc. Announces Co-Pay Program for Oncaspar® (pegaspargase) --

GAITHERSBURG, Md., June 27, 2011 /PRNewswire-USNewswire / -- Today, Sigma-Tau Pharmaceuticals, Inc. announced a vital new service for people with Acute Lymphoblastic Leukemia (ALL).  The Sigma-Tau Outreach Service (S.O.S.) will now refund eligible patients 100 percent of any co-pay associated with their prescription for Oncaspar®.  For more information on eligibility criteria, please call 1-800-490-3262, Monday through Friday, 9 a.m. to 5 p.m. ET.

"It is important to Sigma-Tau that families and patients accessing our medicines do not suffer financial distress," said Gregg Lapointe, Chief Executive Officer, Sigma-Tau Pharmaceuticals, Inc.  "This program is designed to ensure that patients and families battling ALL will not be burdened with co-pays tied to Oncaspar®, regardless of income."    

The S.O.S. resource provides patients, families and healthcare providers with the following free services:

Reimbursement Support:  Trained specialists will help patients understand how to effectively navigate their insurance coverage and address common issues, such as prior authorization or appeals.  Specialists also will work to identify additional benefit programs patients might be eligible to join.

Patient Assistance:  Sigma-Tau Pharmaceuticals, Inc. will provide eligible patients who cannot pay for Oncaspar® with the treatment at no charge.  

Oncaspar ® Co-pay Assistance: Eligible patients will receive 100 percent reimbursement for all co-pays associated with the utilization of Oncaspar® with no limitations on family income or financial status.

"Today's insurance programs are complex.  The trained specialists available through the S.O.S. service can help people navigate insurance coverage and reimbursement concerns.  We're very proud to offer this service, so patients can focus on their treatment," said Lapointe.  

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,747.92 -50.57 -0.28%
S&P 500 2,082.76 -7.35 -0.35%
NASDAQ 5,106.2210 -21.3040 -0.42%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs